Plaintiffs lawyers fighting Takeda Pharmaceuticals U.S.A. over the drugmaker’s spoliation of evidence have denounced as a “whitewash” its recent claim that it is on track to restore the evidence.

Takeda and five related corporations reported that they have recovered 61,000 emails and attachments after a Louisiana federal judge found them liable for spoliation of evidence in litigation over diabetes drug Actos.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]